59 related articles for article (PubMed ID: 15154098)
1. American Chemical Society--227th Annual Meeting. New disclosures. 28 March - 1 April 2004, Anaheim, CA, USA.
Garvey R; Veryard C
IDrugs; 2004 May; 7(5):423-5. PubMed ID: 15154098
[No Abstract] [Full Text] [Related]
2. American Chemical Society--227th annual meeting. Highlights. 28 March - 1 April 2004, Anaheim, CA, USA.
Garvey R; Veryard C
IDrugs; 2004 May; 7(5):426-7. PubMed ID: 15154099
[No Abstract] [Full Text] [Related]
3. American Chemical Society--227th Annual Meeting. Antibacterials and anti-inflammatories. 28 March - 1 April 2004, Anaheim, CA, USA.
Garvey R; Veryard C
IDrugs; 2004 May; 7(5):420-2. PubMed ID: 15154097
[No Abstract] [Full Text] [Related]
4. American Chemical Society--227th Annual Meeting. NMDA receptor. 28 March - 1 April 2004, Anaheim, CA, USA.
Rotella DP
IDrugs; 2004 May; 7(5):433-5. PubMed ID: 15154102
[No Abstract] [Full Text] [Related]
5. American Chemical Society--227th annual meeting. Diabetes. 28 March - 1 April 2004, Anaheim, CA, USA.
Rotella DP
IDrugs; 2004 May; 7(5):428-9. PubMed ID: 15154100
[No Abstract] [Full Text] [Related]
6. American Society of Clinical Oncology-39th Annual Meeting. Investigational Drugs. 31 May-3 June 2003, Chicago, IL, USA.
Erlich R; Durrance A
IDrugs; 2003 Jul; 6(7):628-30. PubMed ID: 12906005
[No Abstract] [Full Text] [Related]
7. American Chemical Society--227th annual meeting. Neuroprotection. 28 March - 1 April 2004, Anaheim, CA, USA.
Rotella DP
IDrugs; 2004 May; 7(5):430-2. PubMed ID: 15154101
[No Abstract] [Full Text] [Related]
8. American Society of Hematology--44th Annual Meeting and Exposition. Drug highlights I. 6-10 December 2002, Philadelphia, PA, USA.
Adekale M
IDrugs; 2003 Jan; 6(1):1-3. PubMed ID: 12838959
[No Abstract] [Full Text] [Related]
9. Effects of retroviral protease inhibitors on proteasome function and processing of HIV-derived MHC class I-restricted cytotoxic T lymphocyte epitopes.
Kelleher AD; Booth BL; Sewell AK; Oxenius A; Cerundolo V; McMichael AJ; Phillips RE; Price DA
AIDS Res Hum Retroviruses; 2001 Jul; 17(11):1063-6. PubMed ID: 11485623
[No Abstract] [Full Text] [Related]
10. Proteasome inhibition results in increased poly-ADP-ribosylation: implications for neuron death.
Keller JN; Markesbery WR
J Neurosci Res; 2000 Aug; 61(4):436-42. PubMed ID: 10931530
[TBL] [Abstract][Full Text] [Related]
11. Rapamycin inhibits proteasome activator expression and proteasome activity.
Wang X; Omura S; Szweda LI; Yang Y; Bérard J; Seminaro J; Wu J
Eur J Immunol; 1997 Nov; 27(11):2781-6. PubMed ID: 9394799
[TBL] [Abstract][Full Text] [Related]
12. Eponemycin exerts its antitumor effect through the inhibition of proteasome function.
Meng L; Kwok BH; Sin N; Crews CM
Cancer Res; 1999 Jun; 59(12):2798-801. PubMed ID: 10383134
[TBL] [Abstract][Full Text] [Related]
13. Lactacystin increases LDL receptor level on HepG2 cells.
Miura H; Tomoda H; Miura K; Takishima K; Omura S
Biochem Biophys Res Commun; 1996 Oct; 227(3):684-7. PubMed ID: 8885994
[TBL] [Abstract][Full Text] [Related]
14. Lactacystin, a specific inhibitor of the proteasome, inhibits human platelet lysosomal cathepsin A-like enzyme.
Ostrowska H; Wojcik C; Omura S; Worowski K
Biochem Biophys Res Commun; 1997 May; 234(3):729-32. PubMed ID: 9175783
[TBL] [Abstract][Full Text] [Related]
15. Proteasome inhibitors block a late step in lysosomal transport of selected membrane but not soluble proteins.
van Kerkhof P; Alves dos Santos CM; Sachse M; Klumperman J; Bu G; Strous GJ
Mol Biol Cell; 2001 Aug; 12(8):2556-66. PubMed ID: 11514635
[TBL] [Abstract][Full Text] [Related]
16. Novel dipeptide aldehydes are proteasome inhibitors and block the MHC-I antigen-processing pathway.
Harding CV; France J; Song R; Farah JM; Chatterjee S; Iqbal M; Siman R
J Immunol; 1995 Aug; 155(4):1767-75. PubMed ID: 7636233
[TBL] [Abstract][Full Text] [Related]
17. Sepsis-induced muscle proteolysis is prevented by a proteasome inhibitor in vivo.
Fischer D; Gang G; Pritts T; Hasselgren PO
Biochem Biophys Res Commun; 2000 Apr; 270(1):215-21. PubMed ID: 10733930
[TBL] [Abstract][Full Text] [Related]
18. Short-lived green fluorescent proteins for quantifying ubiquitin/proteasome-dependent proteolysis in living cells.
Dantuma NP; Lindsten K; Glas R; Jellne M; Masucci MG
Nat Biotechnol; 2000 May; 18(5):538-43. PubMed ID: 10802622
[TBL] [Abstract][Full Text] [Related]
19. Heat-shock protein 70 antisense oligomers enhance proteasome inhibitor-induced apoptosis.
Robertson JD; Datta K; Biswal SS; Kehrer JP
Biochem J; 1999 Dec; 344 Pt 2(Pt 2):477-85. PubMed ID: 10567231
[TBL] [Abstract][Full Text] [Related]
20. The influence of epoxomicin, inhibitor of proteasomal proteolytic activity, on spermiogenesis in Chara vulgaris.
Kwiatkowska M; Wojtczak A; Popłońska K; Teodorczyk M
Folia Histochem Cytobiol; 2003; 41(1):51-4. PubMed ID: 12705480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
